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Abstract: Hypoxia regulates the local expression of angiotensin-generating system in the rat carotid body and the me-
tabolite angiotensin IV (Ang IV) may be involved in the modulation of carotid body function. We tested the hypothesis 
that Ang IV-binding angiotensin AT4 receptors play a role in the adaptive change of the carotid body in hypoxia. The ex-
pression and localization of Ang IV-binding sites and AT4 receptors in the rat carotid bodies were studied with histochem-
istry. Specific fluorescein-labeled Ang IV binding sites and positive staining of AT4 immunoreactivity were mainly found 
in lobules in the carotid body. Double-labeling study showed the AT4 receptor was localized in glomus cells containing 
tyrosine hydroxylase, suggesting the expression in the chemosensitive cells. Intriguingly, the Ang IV-binding and AT4 
immunoreactivity were more intense in the carotid body of chronically hypoxic (CH) rats (breathing 10% oxygen for 4 
weeks) than the normoxic (Nx) control. Also, the protein level of AT4 receptor was doubled in the CH comparing with the 
Nx group, supporting an upregulation of the expression in hypoxia. To examine if Ang IV induces intracellular Ca
2+ 
re-
sponse in the carotid body, cytosolic calcium ([Ca
2+
]i) was measured by spectrofluorimetry in fura-2-loaded glomus cells 
dissociated from CH and Nx carotid bodies. Exogenous Ang IV elevated [Ca
2+
]i in the glomus cells and the Ang IV re-
sponse was significantly greater in the CH than the Nx group. Hence, hypoxia induces an upregulation of the expression 
of AT4 receptors in the glomus cells of the carotid body with an increase in the Ang IV-induced [Ca
2+
]i elevation. This 
may be an additional pathway enhancing the Ang II action for the activation of chemoreflex in the hypoxic response dur-
ing chronic hypoxia. 
Keywords: Angiotensin IV, angiotensin IV receptor, chemoreceptor, type-I cells. 
INTRODUCTION 
 The carotid body is the major peripheral organ respond-
ing to rapid changes in arterial chemical content such as par-
tial pressure of oxygen and carbon dioxide, and plays impor-
tant roles in the cardiopulmonary responses to hypoxia and 
hypercapnic acidosis. Type-I (glomus) cells in the carotid 
body are the chemosensitive cells because they are apposed 
to the nerve endings and are the main cell types containing 
catecholamines, presumably the source of dopamine release 
during sensory transduction of the physiological stimuli [1, 
2]. Essentially, glomus cells elevates cytosolic calcium 
([Ca
2+
]i) levels during hypoxia or hypercapnic acidosis [3-6]. 
The [Ca
2+
]i elevation couples the stimuli to the vesicular se-
cretion of the neurotransmitters including catecholamines, 
acetylcholine and ATP for the increase in afferent nerve ac-
tivity that activates the central responses for the physiologi-
cal changes to compensate metabolic needs. 
 The expression and localization of several key renin-
angiotensin system (RAS) components, notably angiotensio-
gen (AGT), which is an obligatory element for the existence 
of an intrinsic RAS have been demonstrated in the carotid 
body [7]. Protein and mRNA of AGT were specifically lo-
calized to the glomus cells. However, mRNA of renin was  
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not detected while mRNA of angiotensin-converting enzyme 
(ACE) was found [7]. These results suggest that an intrinsic 
angiotensin-generating system is operating in the carotid 
body, probably via a locally renin-independent pathway. 
Hence, the locally produced angiotensin II (Ang II) could act 
via paracrine or autocrine on the angiotensin AT1 receptors 
expressed in the carotid body [8, 9]. 
 Interestingly, chronic hypoxia causes an upregulation of 
the expression and localization of AGT mRNA and protein 
levels in the glomus cells of the rat carotid body [10]. In ad-
dition, mRNA expression of ACE was also increased by 
chronic hypoxia [10]. This is supported by studies with en-
zyme assay showing an increase in ACE activity in the 
chronically hypoxic rat carotid body comparing with the 
normoxic control [11]. These findings suggest that chronic 
hypoxia activates the local components of an intrinsic angio-
tensin-generating system in the rat carotid body. 
 In addition to Ang II and its ligand-binding receptors AT1 
and AT2, recent studies have shown that a metabolite of Ang 
II, a pentapeptide containing the 3-8 fragment of Ang II, 
namely angiotensin IV (Ang IV), is a biologically active 
peptide of the RAS. It has also been demonstrated that high 
affinity binding sites for Ang IV, known as the angiotensin 
AT4 receptor, localized in various tissues such as the rat 
brain and kidney [12-14]. In the brain, Ang IV enhances the 
release of acetylcholine in hippocampal slices and improves 
memory in rats with dementia [15]. Recent studies identified 
AT4 receptor as insulin-regulated aminopeptidase which is a 
member of the M1 family of aminopeptidases [16]. The sig-
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naling cascades coupling to the ligand binding of the AT4 
receptors are not clear and may involve multiple signaling 
pathways [14]. Recent evidence also suggests that an activa-
tion of AT1 receptors could be involved in the cellular effects 
of Ang IV on intracellular signaling events [17, 18]. At the 
moment, the expression of the AT4 receptor in the carotid 
body and its regulation by hypoxia remains unknown. In this 
study, we tested the hypothesis that AT4 receptors are pre-
sent in the rat carotid body and play a role in the adaptive 
change in chronic hypoxia. In addition, we investigated the 
effect of Ang IV on the [Ca
2+
]i level of the glomus cells be-
cause of the physiological significance of the [Ca
2+
]i eleva-
tion in the chemotransduction. 
MATERIALS AND METHODOLOGY 
Preparation of Animals 
 The experimental protocol for this study was approved 
by the Committee on the Use of Live Animals in Teaching 
and Research of the University of Hong Kong and the Ani-
mal Ethical Committee of the Chinese University of Hong 
Kong. For the exposure of rats in normobaric hypoxia [19], 
one-month-old Sprague-Dawley rats were placed in a cham-
ber made of Perspex. The chamber was continuously vented 
by pumping in room air (2 liter/min) and the oxygen fraction 
of the gas inside the chamber was kept at 10+0.5%. The 
oxygen level was continuously monitored by an oxygen ana-
lyser (Vacumed, CA, USA) which provided the servo-
feedback signal for the control of solenoid values which 
gated the inflow of pure nitrogen. Animals were kept in the 
chamber for 4-5 weeks and they were freely accessible to 
water and chow. The humidity and carbon dioxide level was 
maintained by dehumidifier and soda lime. In every 2-3 
days, the chamber was opened for 30 min for regular main-
tenance. For normoxic controls, litters were kept in the same 
room but were supplied with room air. 
Isolation of Carotid Body and Dissociation of Type-I 
Glomus Cells 
 Following deep anesthesia with halothane, rats were de-
capitated and the carotid bifurcation was excised rapidly. For 
the dissociation of glomus cells, the carotid body was care-
fully dissected free from the bifurcation in chilled rat Ringer 
oxygenated with 95% O2 and 5% CO2. The carotid body was 
then incubated in a tissue bath with collagenase (0.06%) and 
protease (0.02%) in oxygenated Ringer for 30 min at 35 ± 
1°C [8]. Following enzymatic treatment, the carotid body 
cells were dispersed by gently triturating with glass pipettes. 
Cells were incubated in 5 μM fura-2 acetoxymethyl ester 
(fura-2AM, Molecular Probes) for 30 min at room tempera-
ture. The cells were then centrifuged at 200 g for 5 min and 
prepared for the spectrofluorimetric measurement of [Ca
2+
]i. 
Glomus cells in clusters of 8-10 cells were studied and the 
morphological criteria for their confirmation as glomus cells 
was according to the methods used in previous reports [8, 
19]. 
Fluorescence-Labeled Binding Assay 
 Carotid bifurcations were excised from normoxic and 
hypoxic rats (n=8) under deep anesthesia. The bifurcations 
were rinsed in PBS and frozen in iso-pentane. Cryosections 
(8 μm) were cut on a Cryostat and fixed with freshly pre-
pared 4% paraformaldehyde (PFA) for 30 min. Sections 
were washed with PBS at room temperature for 10 min and 
then fixed in 2% PFA for 10 min, followed by PBS rinse for 
10 min. After air dry, sections were incubated for 30 min at 
room temperature with one of the following conditions, 
which were described in details in a previous report [20]: (1) 
20 nM fluorescein isothiocyanate (FITC)-labeled Ang IV 
(Auspep, Australia) in 5 ml Ang IV incubation buffer, which 
contained 59.3 μl of 50 μM plummers inhibitor (DL-2-2-
Mercaptomethyl-3-guanidinoetyhiopropanoic acid (Calbio-
chem, CA, USA)) and 17.2 μl of 11 μM bestatin and 30 mg 
of 0.6% BSA in PBS; (2) pre-incubation with 10 μM non-
labeled Ang IV (angiotensin II (3-8) (Auspep, Australia)) for 
15 min followed by 5 mL Ang IV incubation buffer with 20 
nM FITC-labeled Ang IV; (3) 20 nM fluorescein isothiocy-
anate (FITC)-labeled Ang IV in 5 ml Ang IV incubation 
buffer with 4.8 μl of 1mg/ml (1 μM) Sarile ([Sar1, Ile8]-
angiotensin II; Sar-Arg-Val-Tyr-Ile-His-Pro-Ile). Following 
incubation, slides were washed twice in PBS for 1 min and 
then by double distilled water for 30 min at 4°C. Sections 
were dry overnight and examined with a fluorescent micro-
scope with a DC 200 digital camera (Leica Microsystems 
Ltd., Heerbrugg, Switzerland). Non-specific bindings were 
assessed in sections with the non-labeled Ang IV and the 
specific bindings of Ang IV were demonstrated in sections 
with Sarile that is not readily metabolized to Ang III and 
Ang IV. 
Immunohistochemistry 
 Cryosections were then processed for indirect im-
munofluorescent double staining as reported previously [7]. 
Briefly, sections were incubated overnight at 4°C with rabbit 
anti-rat AT4 receptor serum, diluted to 1:1000, followed with 
anti-tyrosine hydroxylase serum (Chemicon International, 
USA), diluted to 1:300 overnight at 4°C. After rinses in PBS, 
the primary antibodies were detected using anti-rabbit serum 
labeled with rhodamine (1:100, Jackson, USA) for AT4 re-
ceptor and anti-sheep serum labeled with AMCA (1:100, 
Jackson, USA) for TH at room temperature for 2 h. Positive 
immunoreactivity for AT4 receptor (red) and for TH (blue) 
was examined with a fluorescent microscope with a DC 200 
digital camera (Leica Microsystems Ltd., Heerbrugg, Swit-
zerland). For the control, primary antibodies were substituted 
with buffer and sections were incubated with rabbit nonim-
mune serum. 
Western Blot Analysis 
 The procedures were reported previously [7]. Carotid 
bodies were dissected free and frozen at -70°C. Carotid bod-
ies (n=20) were homogenized at 4°C in water (1:9, w/v) con-
taining 10 mM EDTA and 1 mM phenylmethylsulphonyl 
fluoride. The protein from resultant supernatant was deter-
mined (Bio-Rad Protein Assay) for sodium dodecy sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE). Proteins 
(5-10 mg/lane) were subjected to electrophoresis on a 12% 
(w/v) polyacrylamide gel in SDS, and the gel was subse-
quently processed for electroblotting to polyvinylidene 
difluoride (PVDF) membrane. The blotted PVDF membrane 
was saturated with 5% (w/v) of skimmed milk in PBS, pH 
7.4 and 0.1% (w/v) of Tween 20 for 1 h at room temperature. 
The membrane was sequentially incubated in rabbit anti-rat 
AT4 receptor serum (1:2500) overnight at 4°C and a horse-
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radish peroxidase-labeled anti-rabbit IgG (1:200 dilution, 
Boehringer Mannheim, Germany) for 2 h at room tempera-
ture. After thorough washing, the positive band was revealed 
using ECL western blotting detection reagents and autora-
diography film (Amersham, Biosciences, UK). The flores-
cence intensity of the bands was quantified using an IMAGE 
QUANT software (Molecular Dynamics, USA). 
Spectrofluorimetric Measurement 
 [Ca
2+
]i was measured in fura-2 loaded glomus cells 
freshly dissociated from rat carotid bodies as described in 
previous studies [8, 19]. The cells were seeded on a cover 
slip placed in the stage of an inverted microscope. The mi-
croscope was coupled with a dual-wavelength excitation 
spectrofluorimeter (Photon Technology International, NJ, 
USA). The cells were perfused with HEPES buffer at 0.5 
ml/min at room temperature (~22°C). The fluorescence in-
tensity in the background was measured and subtracted from 
the signals. Fluorescent signals were obtained at 340 and 380 
nm excitation wavelengths. The ratio of the fluorescence 
intensity (340/380 nm) was used to estimate [Ca
2+
]i in the 
glomus cells. The [Ca
2+
]i was calculated by using the equa-
tion: 
[Ca
2+
]i = Kd [(Ro - Rmin)/(Rmax - Ro)]  
 where Ro is the fluorescence ratio, Rmin is the fluores-
cence ratio at zero Ca
2+
, Rmax is the fluorescence ratio at 
saturated Ca
2+
, Kd is the dissociation constant for fura-2 (224 
nM) and  is the ratio of 380 nm fluorescence intensity at 
zero Ca
2+
 to 380 nm fluorescence intensity at saturated Ca
2+
. 
Experimental Paradigm 
 Dosage dependence was determined by the [Ca
2+
]i re-
sponse to Ang IV at 0.01, 0.1, 1 and 10 μm. Ang IV was 
administered directly into the 0.5 ml chamber with a fine 
pipette without disrupting the fluid in the chamber. At the 
end of the experiment, acute hypoxia was induced by sodium 
cyanide (NaCN, 1 mM, in bolus) to confirm the chemosensi-
tivity of the glomus cells. 
Materials and Pharmacological Agents 
 The rat Ringer solution contained (mM): NaCl 125, KCl 
3.1, NaHCO3 26, NaH2PO4 1.25, MgSO4 1.3, CaCl2 2.4, D-
Dextrose 10. The HEPES Ringer contained (mM): NaCl 140, 
KCl 3, NaH2PO4 1.25, MgCl2 1, CaCl2 1, HEPES 10, D-
Dextrose 25 (pH = 7.35-7.4). Losartan (1 μM) an antagonist 
for AT1 receptors was dissolved in HEPES Ringer solution. 
The concentrations of Ang IV and NaCN were 5 mM and 1 
M, respectively, for the injection. Fura-2AM was dissolved 
in dimethyl sulfoxide (DMSO) in 1 mM stock. Drugs were 
purchased from Sigma or mentioned otherwise. 
Statistical Analysis 
 All gel images from Western blot study were analyzed 
and quantified by an UV illuminator (FluroChem 8000 Ad-
vanced Fluorescence, Chemiluminescence and Visible Light 
Imaging, Alpha Innotech Corporation, CA, USA). For the 
[Ca
2+
]i, the resting and peak values of the fluorescence ratio 
of 340/380 nm or calibrated [Ca
2+
]i (nM) of the responses  
 
during drug treatment were calculated. Values were normal-
ized to% control if needed and were presented as mean ± 
standard error. Statistical comparisons were made with the 
unpaired t-test for comparing the normoxic control and hy-
poxic group. ANOVA with post hoc test (Dunnett’s t-test) 
were used for multiple comparisons of values in drugs stud-
ies among groups with different doses. Differences were 
considered significant at p<0.05. 
RESULTS 
 Specific bindings of FITC-labeled Ang IV were obtained 
in the carotid body and also in the kidney served as a posi-
tive control. Fig. (1) shows the Ang IV-binding sites in the 
Nx (Fig. 1A) and CH (Fig. 1D) carotid body and in the kid-
ney (Fig. 1G). The pattern of the labeling illustrates that the 
binding sites were localized in glomerular clusters in the 
carotid bodies, suggesting the expression in the chemosensi-
tive glomus cells. In addition, the intensity of the fluores-
cence labeling was more intense in the CH than that of the 
Nx group. The binding was abolished by prior incubation of 
the sections with Ang IV without FITC labeling (Fig. 
1B,E,H). Also, the FITC-labeled Ang IV binding was not 
affected by the addition of excessive amount of Sarile (Fig. 
1C,F,I), which saturated the AT1 and AT2 binding sites. 
 The localization of protein expression of the AT4 recep-
tors in the carotid body is shown in Fig. (2). Positive staining 
of AT4 receptor-immunoreactivity was obtained in Nx and 
CH carotid bodies (Fig. 2C,D). The immunostaining was 
localized in lobules of the carotid body, which was also posi-
tively stained with TH-immunoreactivity (Fig. 2A,B), con-
firming that the AT4 receptor expression was in the che-
mosensitive glomus cell. Additionally, the intensity of the 
staining was at a high level in the CH comparing with that of 
the Nx group, indicating an increase in AT4 receptor expres-
sion in the CH carotid body. 
 To examine the protein expression of AT4 receptor in the 
Nx and CH rat carotid bodies, Western blot analysis was 
performed and results are shown in Fig. (3). The level of 
protein expression increased significantly (p<0.05) by about 
two folds in the CH comparing with the Nx group. The AT4 
receptor was also expressed in the hippocampus served as 
the positive control. 
 To investigate whether Ang IV stimulates intracellular 
Ca
2+ 
response in the carotid body, the [Ca
2+
]i level was 
measured by spectrofluorimetry in fura-2-loaded glomus 
cells dissociated from the carotid bodies. Exogenous Ang IV 
(10 μM) elevated [Ca2+]i in clusters of glomus cells, although 
0.1-1 μM Ang IV had only negligible effects on the [Ca2+]i 
levels (Fig. 4). The peak [Ca
2+
]i level was reached shortly 
following Ang IV stimulation and the [Ca
2+
]i levels gradu-
ally returned to the resting level within 3 minutes. In the CH 
glomus cells, the peak [Ca
2+
]i response to Ang IV was sig-
nificantly greater that that of the Nx group (Fig. 4). On aver-
age, the levels of [Ca
2+
]i elevation induced by Ang IV (10 μM) were 51.0 ± 10.1 nM (n=9) and 13.4 ± 4.6 nM (n=7), 
respectively, in the CH and Nx group. Histotoxic hypoxia 
with sodium cyanide (1 mM) increased the [Ca
2+
]i level in all 
of the glomus cells. Results suggest that Ang IV can activate 
the [Ca
2+
]i response in the chemosensitive glomus cells and 
that the Ang IV-induced [Ca
2+
]i response is enhanced by CH. 
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Fig. (1). Angiotensin IV (Ang IV)-binding sites in normoxic (Nx) and chronically hypoxic (CH) rat carotid body. Panels on top show FITC-
coupled Ang IV binding (A), + Ang IV (B), + Sarile (C) in Nx group. Panels in middle show FITC-coupled Ang IV binding (D), + Ang IV 
(E), + Sarile (F) in CH group. Panels at bottom show FITC-coupled Ang IV binding (G), + Ang IV (H), + Sarile (I) in rat kidney, which was 
used as the positive control. Concentration of FITC-coupled Ang IV, unlabeled Ang IV and Sarile were 0.2, 10, 1 μM, respectively. Calibra-
tion bar is 20 μm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). The expression and localization of AT4 receptor-immunoreactivity in (A) Nx and (B) CH rat carotid body. Note the intensity of 
staining is at a high level in the CH comparing with that of the Nx group. Sections with tyrosine hydroxylase (TH) for the Nx and CH carotid 
bodies are shown in C and D. E and F are overlays of the AT4 receptor- and TH-stainings. Calibration bars are 20 and 50 μm, respectively, 
for low (A, C, E) and high magnification (B, D, F). 
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Fig. (3). Protein expression of AT4 receptors in Nx and CH rat ca-
rotid body. Note the level of protein expression increased signifi-
cantly in the CH group. The expression in the hippocampus serves 
as the positive control. Densitometric analysis depicts the relative 
expression of AT4 receptor protein in the CH group of carotid bod-
ies and the expression is normalized as percent of the Nx group. 
Statistical significance (n=5, p<0.05, unpaired-t test) is shown in 
asterisk when comparing with the Nx group. 
DISCUSSION 
 This is the first study to demonstrate an expression of 
AT4 receptors in the rat carotid body and its upregulation in 
chronic hypoxia. Hence, using FITC-labeled Ang IV, a low 
intensity of binding is present in the rat carotid body. This is 
also supported by the positive staining of immunoreactivity 
against the AT4 receptor, which is co-localized with the tyro-
sine hydroxylase (TH)-positive glomus cell in the carotid 
body. In fact, the results of the FITC study are consistent 
with the immunohistochemical findings. The FITC-labeled 
cells were found in glomerular clusters of the carotid body, 
which is a main histological feature of the glomus cells. 
These lobules of chemosensitive cells are positive with the 
immunoreactivity of AT4 receptor, which contain TH for the 
synthesis of catecholamines as one of the neurotransmitters 
released during chemotransduction. Ang IV is a metabolite 
of Ang II and binds to distinct AT4 receptors that are local-
ized in various tissues such as the brain and kidney [12-14]. 
In the carotid body, the Ang IV-binding of the AT4 receptor 
is highly specific because the fluorescein-coupled Ang IV 
binding was not displaced by Sarile, which is a ligand of the 
AT1 and AT2 receptors, whereas displaced by the presence of 
excess Ang IV. In addition, distinct AT4 receptors are local-
ized in TH-positive glomus cells, implying a functional role 
in the modulation of the activity of the glomus cells. This 
may enhance the excitatory effect of Ang II on the carotid 
chemoreceptor mediated by the AT1 receptors that are also 
expressed in the glomus cells. 
 Our results suggest an upregulation of the expression of 
AT4 receptors in the carotid body in chronic hypoxia. Hence, 
we found an increased intensity of staining of the Ang IV-
binding sites and AT4 receptors in the CH when comparing 
with that of the Nx carotid bodies. Quantitatively, the ex-
pression of AT4 receptors had a 2-fold increase in the CH 
carotid bodies comparing with the Nx control. Thus the AT4 
receptor could be complementary to the RAS component in 
the carotid body, because of its upregulation by chronic hy-
poxia. Previous studies have shown that chronic hypoxia 
increases chemoreceptor sensitivity to Ang II in the rat ca-
rotid body [19, 21]. The augmentation of Ang II sensitivity is 
mediated by an upregulation of AT1 receptors in the glomus 
cells of the carotid body [19, 21]. These results are consistent 
with the idea that an upregulation of the RAS in the carotid 
body plays a prominent role in the local adaptive response to 
hypoxia. 
 Ang IV and the AT4 receptors have been reported to be 
involved in diverse functions, including blood flow regula-
tion [22, 23], learning and memory function [24, 25], cell 
growth [26-28] and anti-apoptosis [29]. We found that Ang 
IV can induce a significantly greater [Ca
2+
]i elevation in the 
CH glomus cells than that of the Nx control, supporting the 
idea that the upregulation of the AT4 receptor plays a func-
tional role in the carotid response to chronic hypoxia. In this 
context, Lochard et al. [17] reported that Ang IV can mobi-
lize [Ca
2+
]i via AT1 receptors mediated by an allosteric 
mechanism and that AT1 receptor antagonist can block the 
hypertension in transgenic mice with Ang IV release in the 
brain. Also, it has been shown that Ang IV stimulates tyro-
sine kinases activities via an AT1 receptor pathway in the rat 
pituitary tumor cells [18]. Furthermore, it is likely that mul-
tiple pathways and intracellular signals mediate the cellular 
effects of AT4 receptors on the carotid chemosensitive cells. 
It has been proposed that Ang IV (1) can act as potent inhibi-
tor of insulin-regulated aminopeptidase, which may prolong 
the action of endogenous promnestic peptides; (2) may 
modulate glucose uptake by modulating trafficking of glu-
cose transporters; (3) may transduce the signal initiated by 
ligand binding to its C-terminal domain to the intracellular 
domain that interacts with several cytoplasmic proteins [14]. 
Hence, activation of AT4 receptors in the glomus cells may 
interact with the AT1 receptor and its signalling pathway, and 
so this may activate protein kinase C for the Ang IV-induced 
[Ca
2+
]i response. Although we can not rule out the possibility 
that Ang IV may directly activate the AT1 receptor with a 
dosage of exogenous Ang IV in the micromolar range, our 
binding studies with Sarile did not support the interpretation 
of such a non-specific binding of Ang IV to the AT1 receptor. 
Nevertheless, the functional significance of the AT4 receptor 
expression may not be fully reflected by the [Ca
2+
]i response 
induced by Ang IV and the details of the Ang IV action and 
possible interaction with the AT1 receptors and its signaling 
cascades await elucidation by further studies. Also, potential 
roles of Ang IV in heart failure and other cardiovascular dis-
eases remain to be investigated with different animal models 
or experimental settings, which can not be closely mimicked 
by chronic hypoxia. 
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 AT4 receptors could play a more prominent role follow-
ing its upregulation in chronic hypoxia. This is in parallel to 
the fact that the expression and function of the local RAS in 
the carotid body is also upregulated in chronic hypoxia [9]. 
Presumably, this can increase the amount of Ang II locally 
produced in the carotid body, which in turn causes an ele-
vated level of Ang IV for the activation of intracellular sig-
naling cascade leading to the [Ca
2+
]i elevation. Moreover, 
circulating RAS is stimulated by acute hypoxia [30, 31] and 
chronic hypoxia [32, 33]. The plasma Ang II level increases 
during hypoxic conditions [34] and peripheral infusion of 
Ang II stimulates ventilation [35, 36]. Thus, the functional 
AT4 receptor in the carotid body may be an additional path-
way enhancing the Ang II action for the activation of 
chemoreflex and sympathetic activity as well as functional 
changes such as in the hypoxic sensory response during pro-
longed hypoxia. Also, through unknown mechanisms possi-
bly involving the carotid chemoreceptor, chronic hypoxia 
causes diuresis and sodium depletion; hence enhances the 
physiological responses to retain salt and water for the fluid 
balance [37]. The activation of AT4 receptors in the carotid 
body may be an additional pathway enhancing the Ang II 
action for the activation of chemoreflex in the physiological 
response during chronic hypoxia. 
ACKNOWLEDGEMENTS 
 The authors gratefully acknowledge Dr. Siew Yeen Chai 
at Howard Florey Institute, University of Melbourne, Austra-
lia. SYC are kindly enough to give the AT4 receptor antibody 
as a gift and provide technical advice on the use of the anti-
body. We also thank Mr. W. B. Wong for his technical assis-
tance. The study was supported by grants (HKU 7510/06M) 
from the Research Grants Council, HKSAR, and the Univer-
sity Grants Committee in HKU and in CUHK. 
REFERENCES 
[1] Gonzalez C, Almaraz L, Obeso A, Rigual R. Carotid body 
chemoreceptors: from natural stimuli to sensory discharges. Physiol 
Rev 1994; 74: 829-98. 
[2] Lahiri S, Rozanov C, Roy A, Storey B, Buerk DG. Regulation of 
oxygen sensing in peripheral arterial chemoreceptors. Int J Bio-
chem Cell Biol 2001; 33: 755-74. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). The [Ca
2+
]i response to exogenous Ang IV in dissociated glomus cells of the rat carotid body from Nx control (A) and CH group 
(B). The records were made in cluster of 8-10 cells loaded with fura-2. Ang IV-induced [Ca
2+
]i elevation was more significant in the CH 
glomus cells than that of the Nx group. Note that the transient [Ca
2+
]i increase following the injection of Ang IV (0.01-10 μM) into the bath. 
In addition, histotoxic hypoxia with sodium cyanide (NaCN, 1 mM) increased the [Ca
2+
]i of the cells. Results are summarized in (C). On 
average, the [Ca
2+
]i elevation (R (340/380)) induced by 10 μM Ang IV in the CH group (n=9) was significantly greater than that of the Nx 
control (n=7). Statistical significance (p<0.05, unpaired-t test) is shown in asterisk when comparing with the other groups. 
Carotid Body AT4 Receptor in Hypoxia The Open Cardiovascular Medicine Journal, 2007, Volume 1    7 
[3] Biscoe TJ, Duchen MR, Eisner DA, O'Neill SC, Valdeolmillos M. 
Measurements of intracellular Ca2+ in dissociated type I cells of 
the rabbit carotid body. J Physiol 1989; 416: 421-34. 
[4] Buckler KJ, Vaughan-Jones RD. Effects of hypercapnia on mem-
brane potential and intracellular calcium in rat carotid body type I 
cells. J Physiol 1994; 478 (Pt 1): 157-71. 
[5] Dasso LL, Buckler KJ, Vaughan-Jones RD. Interactions between 
hypoxia and hypercapnic acidosis on calcium signaling in carotid 
body type I cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: 
L36-42. 
[6] Roy A, Rozanov C, Mokashi A, Lahiri S. P(O(2))-P(CO(2)) stimu-
lus interaction in [Ca(2+)](i) and CSN activity in the adult rat ca-
rotid body. Respir Physiol 2000; 122: 15-26. 
[7] Lam SY, Leung PS. A locally generated angiotensin system in rat 
carotid body. Regul Pept 2002; 107: 97-103. 
[8] Fung ML, Lam SY, Chen Y, Dong X, Leung PS. Functional ex-
pression of angiotensin II receptors in type-I cells of the rat carotid 
body. Pflugers Arch 2001; 441: 474-80. 
[9] Leung PS, Fung ML, Tam MS. Renin-angiotensin system in the 
carotid body. Int J Biochem Cell Biol 2003; 35: 847-54. 
[10] Lam SY, Leung PS. Chronic hypoxia activates a local angiotensin-
generating system in rat carotid body. Mol Cell Endocrinol 2003; 
203: 147-53. 
[11] Lam SY, Fung ML, Leung PS. Regulation of the angiotensin-
converting enzyme activity by a time-course hypoxia in the carotid 
body. J Appl Physiol 2004; 96: 809-13. 
[12] Roberts KA, Krebs LT, Kramar EA, Shaffer MJ, Harding JW, 
Wright JW. Autoradiographic identification of brain angiotensin IV 
binding sites and differential c-Fos expression following intracere-
broventricular injection of angiotensin II and IV in rats. Brain Res 
1995; 682: 13-21. 
[13] Handa RK, Krebs LT, Harding JW, Handa SE. Angiotensin IV 
AT4-receptor system in the rat kidney. Am J Physiol 1998; 274: 
F290-99. 
[14] Chai SY, Fernando R, Peck G, et al. The angiotensin IV/AT4 re-
ceptor. Cell Mol Life Sci 2004; 61: 2728-37. 
[15] Albiston AL, Fernando R, Ye S, Peck GR, Chai SY. Alzheimer's, 
angiotensin IV and an aminopeptidase. Biol Pharm Bull 2004; 27: 
765-67. 
[16] Albiston AL, McDowall SG, Matsacos D, et al. Simpson RJ, Con-
nolly LM, Chai SY. Evidence that the angiotensin IV (AT(4)) re-
ceptor is the enzyme insulin-regulated aminopeptidase. J Biol 
Chem 2001; 276: 48623-26. 
[17] Lochard N, Thibault G, Silversides DW, Touyz RM, Reudelhuber 
TL. Chronic production of angiotensin IV in the brain leads to hy-
pertension that is reversible with an angiotensin II AT1 receptor an-
tagonist. Circ Res 2004; 94: 1451-7. 
[18] Rebas E, Lachowicz-Ochedalska A, Pawlikowski M. Angiotensin 
IV stimulates the activity of tyrosine kinases in rat anterior pituitary 
gland acting via AT1-like receptors? J Physiol Pharmacol 2004; 55: 
107-11. 
[19] Fung ML, Lam SY, Dong X, Chen Y, Leung PS. Postnatal hy-
poxemia increases angiotensin II sensitivity and up-regulates AT1a 
angiotensin receptors in rat carotid body chemoreceptors. J Endo-
crinol 2002; 173: 305-13. 
[20] von Bohlen und Halbach O, Albrecht D. Identification of angio-
tensin IV binding sites in the mouse brain by a fluorescent binding 
study. Neuroendocrinology 2000; 72: 218-23. 
[21] Leung PS, Lam SY, Fung ML. Chronic hypoxia upregulates the 
expression and function of AT(1) receptor in rat carotid body. J 
Endocrinol 2000; 167: 517-24. 
[22] Coleman JK, Krebs LT, Hamilton TA, et al. Autoradiographic 
identification of kidney angiotensin IV binding sites and angio-
tensin IV-induced renal cortical blood flow changes in rats. Pep-
tides 1998; 19: 269-77. 
[23] Patel JM, Martens JR, Li YD, Gelband CH, Raizada MK, Block 
ER. Angiotensin IV receptor-mediated activation of lung endothe-
lial NOS is associated with vasorelaxation. Am J Physiol 1998; 
275: L1061-8. 
[24] Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV 
system: functional implications. Front Neuroendocrinol 1995; 16: 
23-52. 
[25] Pederson ES, Harding JW, Wright JW. Attenuation of scopola-
mine-induced spatial learning impairments by an angiotensin IV 
analog. Regul Pept 1998; 74: 97-103. 
[26] Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Hard-
ing JW. Characterization of a functional angiotensin IV receptor on 
coronary microvascular endothelial cells. Regul Pept 1995; 58: 
107-15. 
[27] Moeller I, Paxinos G, Mendelsohn FA, Aldred GP, Casley D, Chai 
SY. Distribution of AT4 receptors in the Macaca fascicularis brain. 
Brain Res 1996; 712: 307-24. 
[28] Pawlikowski M, Kunert-Radek J. Angiotensin IV stimulates the 
proliferation of rat anterior pituitary cells in vitro. Biochem Bio-
phys Res Commun 1997; 232: 292-3. 
[29] Kakinuma Y, Hama H, Sugiyama F, Goto K, Murakami K, Fu-
kamizu A. Anti-apoptotic action of angiotensin fragments to neu-
ronal cells from angiotensinogen knock-out mice. Neurosci Lett 
1997; 232: 167-70. 
[30] Liang CS, Gavras H. Renin-angiotensin system inhibition in con-
scious dogs during acute hypoxemia. Effects on systemic hemody-
namics, regional blood flows, and tissue metabolism. J Clin Invest 
1978; 62: 961-70. 
[31] Raff H, Roarty TP. Renin, ACTH, and aldosterone during acute 
hypercapnia and hypoxia in conscious rats. Am J Physiol 1988; 
254: R431-5. 
[32] Gould AB, Goodman SA. The effect of hypoxia on the renin-
angiotensinogen system. Lab Invest 1970; 22: 443-7. 
[33] Ip SP, Chan YW, Leung PS. Effects of chronic hypoxia on the 
circulating and pancreatic renin-angiotensin system. Pancreas 
2002; 25: 296-300. 
[34] Zakheim RM, Molteni A, Mattioli L, Park M. Plasma angiotensin 
II levels in hypoxic and hypovolemic stress in unanesthetized rab-
bits. J Appl Physiol 1976; 41: 462-5. 
[35] Ohtake PJ, Jennings DB. Angiotensin II stimulates respiration in 
awake dogs and antagonizes baroreceptor inhibition. Respir Physiol 
1993; 91: 335-51. 
[36] Potter EK, McCloskey DI. Respiratory stimulation by angiotensin 
II. Respir Physiol 1979; 36: 367-73. 
[37] Honig A. Peripheral arterial chemoreceptors and reflex control of 
sodium and water homeostasis. Am J Physiol 1989; 257: R1282-
1302. 
 
 
Received: May 21, 2007 Revised: May 30, 2007 Accepted: June 1, 2007 
 
 
 
 
